Dr. Amarilis Torres, MD
What this data tells you about Dr. Torres
Dr. Amarilis Torres is a rheumatology in Zephyrhills, FL, with 19 years in practice. Based on federal Medicare data, Dr. Torres performed 203,860 Medicare services across 1,531 unique beneficiaries.
Between the years covered by Open Payments, Dr. Torres received a total of $21,548 from 42 pharmaceutical and/or device companies across 1239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Torres is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 75,200 | $4 | $20 |
| Tocilizumab injection (Actemra) | 60,191 | $5 | $12 |
| Romosozumab injection (Evenity) for osteoporosis | 26,250 | $8 | $23 |
| Infliximab infusion (Remicade) | 16,210 | $26 | $180 |
| Golimumab infusion (Simponi Aria) | 12,150 | $11 | $56 |
| Denosumab injection (Prolia/Xgeva) | 5,820 | $18 | $47 |
| Abatacept infusion (Orencia) | 3,925 | $34 | $131 |
| Drug injection, under skin or into muscle | 642 | $11 | $41 |
| Blood draw (venipuncture) | 619 | $8 | $19 |
| Office visit, established patient (20-29 min) | 482 | $66 | $186 |
| Administration of chemotherapy into vein, 1 hour or less | 358 | $99 | $345 |
| Office visit, established patient (30-39 min) | 313 | $85 | $273 |
| Injection, ketorolac tromethamine, per 15 mg | 271 | $0 | $1 |
| Administration of chemotherapy into vein, each additional hour | 269 | $22 | $75 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 228 | $55 | $195 |
| Injection, methylprednisolone acetate, 40 mg | 163 | $6 | $16 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 128 | $49 | $176 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 128 | $98 | $462 |
| Office visit, established patient, complex (40-54 min) | 102 | $126 | $366 |
| Joint injection, major joint | 99 | $60 | $232 |
| Bone density scan (DEXA) | 91 | $36 | $99 |
| Injection, zoledronic acid, 1 mg | 85 | $6 | $157 |
| Flu vaccine administration | 42 | $30 | $74 |
| Flu vaccine, high-dose | 36 | $72 | $184 |
| Injection, methylprednisolone acetate, 80 mg | 36 | $9 | $31 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $18 | $56 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
2.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Torres is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Torres experienced with certolizumab injection (cimzia)?
Does Dr. Torres receive payments from pharmaceutical companies?
How do Dr. Torres's costs compare to other rheumatologys in Zephyrhills?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology